Last reviewed · How we verify

NCT05656937

Oblique Versus Transverse Orientation Approach for Internal Jugular Venous Cannulation in Pediatrics

Completed NA Last updated 19 December 2022
What this trial tests

NA trial testing internal jugular venous cannulation in Heart; Surgery, Heart, Functional Disturbance as Result in 60 participants. Completed in 31 May 2021.

Timeline
1 February 2021
Primary endpoint
31 May 2021
31 May 2021

Quick facts

Lead sponsorIndonesia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date1 February 2021
Primary completion31 May 2021
Estimated completion31 May 2021
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

Adults 3 to 12, any sex, with Heart; Surgery, Heart, Functional Disturbance as Result or Pediatric ALL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study aimed to compare oblique versus transverse orientation approach in jugular venous cannulation in term of cannulation success in pediatric heart surgery patients

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomized Comparison of Oblique versus Transverse Orientation for Ultrasound-Guided Internal Jugular Venous Cannulation in Pediatric Heart Surgery Patients.
    Heriwardito A, Manggala SK, Christina A. · · 2025 · PMID 40237661 · DOI 10.4103/aca.aca_167_24

Verify or expand the search:

Other recruiting trials for Heart; Surgery, Heart, Functional Disturbance as Result

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05656937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing